Why is BP stock surging amid Shell merger talks?
How will Fannie Mae treat crypto assets in mortgages?
Why is Bumble cutting 30% of its workforce?
What impact will Fed’s capital rule changes have?
How did Zohran Mamdani’s win affect NYC real estate?
Why are Tesla sales dropping in Europe?
How are tariff tensions affecting Fed rate decisions?
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity
investors.com/news/technology/viking-therapeutics-stock-weight-loss-drugs-phase-3-testing
Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off.
The post Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-25 18:07:40.